The CMO/CDMO biotechnology market is expected to see significant growth in 2022. Contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) play a vital role in the biotechnology industry by providing outsourcing services for the development, production, and manufacturing of biopharmaceuticals. These services can include cell line development, process development, analytical testing, and clinical and commercial manufacturing.
Global revenue from the CMO/CDMO biotechnology market stands at US$ 10.2 Bn in 2022, with the worldwide market estimated to surge ahead at a CAGR growth value of 11.6% to reach a valuation of around US$ 34.1 Bn by the end of 2033.
CMO/CDMO Biotechnology Market Size (2022) | US$ 10.2 Bn |
Projected Market Value (2033) | US$ 34.1 Bn |
Global Market Growth Rate (2023-2033) | 11.6% CAGR |
Market Share of Top 5 Countries | 69.2% |
Request For Free Sample Report of “Systemic Scleroderma Treatment Market”@ https://www.persistencemarketresearch.com/samples/32516
The increasing demand for biologics and the growing need for cost-effective and efficient production methods are driving the growth of the CMO/CDMO biotechnology market. The market is also being driven by the increasing focus on the development of personalized and targeted therapies, which requires specialized manufacturing processes and technologies.
Companies
- Patheon N.V.
- Catalent
- Samsung Biologics Co., Ltd
- Boehringer Ingelheim
- Samsung BioLogics
- AGC Biologics, Inc.
- WuXi Biologics
- AbbVie Inc
- Avid Bioservices, Inc.
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/32516
In addition, the rising trend of outsourcing production to CMOs and CDMOs is expected to contribute to the growth of the market. This trend is driven by factors such as the increasing complexity of biologics production, the need for specialized expertise and equipment, and the pressure to reduce costs and improve efficiency.
Overall, the CMO/CDMO biotechnology market is expected to experience strong growth in 2022, driven by the increasing demand for biologics and the need for cost-effective and efficient production methods.
Competitive Landscape
Key players are concentrating on expansion in emerging regions and new revised product manufacturing. Market participants are also working to strengthen their expansion, new product launches, and improved distribution channels such as online sources of advertisement.
For instance:
- For instance, Iovance Biotherapeutics chose Avid Bioservices in August 2020 to spearhead process development through cGMP manufacture of IOV-3001, an innovative anti-cancer medication candidate and new IL-2 analogue.
- Fujifilm Diosynth Biotechnologies in April 2021, announced the establishment of its new Microbial production facility in the U.K. The aim of this expansion was to triple the existing microbial production. This new production facility was equipped with 2*2000L of fermenters and modular purification suits.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/32516
Key Segments Covered in Shingles Vaccine Industry Survey
Shingles Vaccine Market by Product type:
- Shingles
- Zostavax
- Sky Zoster
Shingles Vaccine Market by Vaccine type:
- Recombinant Vaccine
- Live Attenuated Vaccine
Shingles Vaccine Market by Region:
- North America Shingles Vaccine Market
- Latin America Shingles Vaccine Market
- Europe Shingles Vaccine Market
- South Asia Shingles Vaccine Market
- East Asia Shingles Vaccine Market
- Oceania Shingles Vaccine Market
- Middle East & Africa Shingles Vaccine Market
For More Premium Insights, Check out the Link:
About Us
Persistence Market Research’s Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on [email protected].